• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number EVR35-06-060-080
Device Problem Inaccurate Delivery (2339)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 08/31/2017
Event Type  Injury  
Event Description
The physician was attempting to use a everflex stent with entrust delivery system to treat a lesion in the right proximal cfa.The target lesion was moderately calcified, 40 mm and had 50% stenosis.The artery had little tortuosity and was 5.5 mm in diameter.There were no abnormalities reported in relation to the patient¿s anatomy.The device was prepped as per the ifu with no issues identified.No damage was noted to the device or it's packaging.The procedure utilized a 6 fr 11 cm sheath and a guidewire.Embolic protection was not used.The lesion was pre-dilated to 5mm.The device was not passed through a previously deployed stent and no resistance was encountered upon advancement, excessive force was not used.It was reported that the surgeon successfully placed the undeployed stent delivery system within the lesion margins prior to deployment, and there was sufficient distal landing zone.During deployment, the stent jumped forward and it was reported that the delivery system had to be forced to stay in place and that it was difficult to control this adequately.As a result, the stent jumped forward and was inaccurately deployed outside of the target site.The proximal end of the stent landed in the middle of the target lesion.The stent deployment system was safely removed and a second everflex entrust was successfully deployed to adequately cover the lesion and complete the procedure.Angiographic latency results were satisfactory.No patient injury reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6904395
MDR Text Key87779943
Report Number2183870-2017-00421
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeNZ
PMA/PMN Number
P110023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/19/2019
Device Catalogue NumberEVR35-06-060-080
Device Lot NumberA331268
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/31/2017
Date Device Manufactured08/19/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient Weight59
-
-